Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.14
+0.34 (1.18%)
Jul 28, 2026, 11:57 AM EDT - Market open
Genmab Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,901 | 3,720 | 3,121 | 2,390 | 2,088 | 1,287 |
Revenue Growth | 27.49% | 19.19% | 30.59% | 14.48% | 62.20% | -22.45% |
Gross Profit Gross Profit Growth | 3,640 | 3,482 | 2,978 | 2,357 | 2,088 | 1,287 |
Operating Income Operating Income Growth | 1,057 | 1,065 | 972 | 772 | 902.02 | 451.59 |
Net Income Net Income Growth | 737 | 963 | 1,133 | 631 | 784.72 | 452.2 |
Earnings Per Share EPS Growth | 1.32 | 1.54 | 1.75 | 0.96 | 1.19 | 0.68 |
EPS Growth | -25.16% | -12.32% | 82.98% | -19.50% | 75.00% | -42.86% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
DARZALEX Royalties DARZALEX Royalties Growth | 2,443 | 2,443 | 2,019 | 1,635 | 1,435 | 928.52 |
Kesimpta Royalties Kesimpta Royalties Growth | 443 | 443 | 323 | 217 | 112.15 | 35.95 |
TEPEZZA Royalties TEPEZZA Royalties Growth | 105 | 105 | 106 | 102 | 114.6 | 90.71 |
Other Product Royalties Other Product Royalties Growth | 111 | 111 | 69 | 35 | 5.9 | 2.14 |
Net Product Sales Net Product Sales Growth | 398 | 398 | 253 | 61 | - | - |
Reimbursement Reimbursement Growth | 53 | 53 | 144 | 124 | 117.77 | 81.23 |
Milestone Milestone Growth | 97 | 97 | 145 | 171 | 254.4 | 145.93 |
Collaboration Collaboration Growth | 70 | 70 | 62 | 45 | 47.8 | 3.06 |
Revenue (Total) Revenue (Total) Growth | 3,720 | 3,720 | 3,121 | 2,390 | 2,088 | 1,287 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,521 | 1,715 | 2,954 | 4,166 | 3,213 | 2,957 |
Total Debt Total Debt Growth | 5,351 | 5,426 | 144 | 114.01 | 85.93 | 64.99 |
Net Cash (Debt) Net Cash Growth | -3,830 | -3,711 | 2,810 | 4,052 | 3,127 | 2,892 |
Net Cash Growth | - | - | -30.65% | 29.56% | 8.12% | 11.80% |
Net Cash Per Share Net Cash Per Share Growth | -6.85 | -5.92 | 4.35 | 6.15 | 4.74 | 4.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 601 | 1,186 | 1,126 | 1,071 | 563.06 | 340.72 |
Capital Expenditures CapEx Growth | -17 | -37 | -27 | -53 | -45.63 | -38.54 |
Free Cash Flow Free Cash Flow Growth | 584 | 1,149 | 1,099 | 1,018 | 517.44 | 302.18 |
Free Cash Flow Growth | -25.42% | 4.55% | 7.96% | 96.74% | 71.23% | -69.95% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 93.31% | 93.60% | 95.42% | 98.62% | 100.00% | 100.00% |
Operating Margin | 27.10% | 28.63% | 31.14% | 32.30% | 43.21% | 35.08% |
Pretax Margin | 23.20% | 32.37% | 42.49% | 34.18% | 47.88% | 46.55% |
Profit Margin | 18.89% | 25.89% | 36.30% | 26.40% | 37.59% | 35.13% |
FCF Margin | 14.97% | 30.89% | 35.21% | 42.59% | 24.78% | 23.48% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.71 | 20.04 | 11.91 | 33.24 | 35.61 | 58.18 |
P/FCF Ratio | 20.44 | 17.22 | 12.57 | 20.67 | 54.02 | 86.03 |
PS Ratio | 4.57 | 5.32 | 4.43 | 8.80 | 13.39 | 20.20 |